BALTIMORE — A special late-breaking session at the ACOG Annual Scientific & Clinical meeting featured the most up-to-date information and guidance on availability of the abortion drug mifepristone. Kristyn M. Brandi, MD, MPH, FACOG, the Darney-Landy Fellow at ACOG for 2022-2023 and OB/GYN physician and complex family planning subspecialist, discussed the current controversy